Slide 1

Can We Restrict RT to PET +’ve Residual Masses?

• GHSG HD11 informs us more intensive chemotherapy BEACOPP

esc.

can

lead to sparing of use of RT to PET +ve patients.

• Should not apply the same rules for RT after ABVD

• Reducing RT consolidation after ABVD in advanced HL likely to increase relapse rate ?.